tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Tiago Fauth, 162 are a BUY (76.06%), 44 are a HOLD (20.66%), 7 are a SELL (3.29%).
Analyst Tiago Fauth, currently employed at WELLS FARGO, carries an average stock price target met ratio of 45.38% that have a potential upside of 23.53% achieved within 123 days. Previously, Tiago Fauth worked at CREDIT SUISSE.
Tiago Fauth’s has documented 424 price targets and ratings displayed on 43 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on INSM, Insmed at 31-Oct-2025.
Analyst best performing recommendations are on HGEN (HUMANIGEN).
The best stock recommendation documented was for HGEN (HUMANIGEN) at 7/13/2022. The price target of $0.5 was fulfilled within 2 days with a profit of $0.11 (18.03%) receiving and performance score of 90.16.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 07-Jul-2025
$4
$-3.38 (-45.80%)
$5
8 months 2 days ago
(07-Nov-2025)
2/2 (100%)
$0.09 (2.30%)
9
Hold Since 05-Nov-2024
10 months 26 days ago
(13-Aug-2025)
0/3 (0%)
$6.55 (120.18%)
Buy Since 05-Jan-2021
$7
$-0.38 (-5.15%)
$10
11 months 1 days ago
(08-Aug-2025)
1/7 (14.29%)
$2.75 (64.71%)
322
Buy Since 05-Dec-2023
$10
$2.62 (35.50%)
$5
11 months 25 days ago
(14-Jul-2025)
7/9 (77.78%)
$5.76 (135.85%)
458
Buy Since 16-May-2025
$10
$2.62 (35.50%)
1 years 1 months 23 days ago
(16-May-2025)
0/1 (0%)
$7.97 (392.61%)
What Year was the first public recommendation made by Tiago Fauth?
